Research Triangle Park, NC (PressExposure) March 12, 2008 -- BioSignia, a predictive modeling company delivering innovative solutions, announced today it has been selected as a data-submission pathway for Bridges to Excellence® (BTE), one of the nation's leading programs to promote care quality within physician practices. This decision rests on BioSignia’s Know Your Number®, the first disease-specific risk assessment (DRA) tool that predicts an individual’s likelihood of developing chronic preventable diseases such as heart disease and diabetes. The Know Your Number solution provides key elements to facilitate the BTE process and mission.

“This relationship allows BioSignia to further leverage Know Your Number to the physician community,” says Dr. Tim Smith, president and COO of BioSignia. “Because Know Your Number was created as a clinical assessment, it’s the perfect tool to help drive care quality among this particular group of medical professionals.”

The Know Your Number program employs electronic evidence-based intake associated with the collection of key information related to various chronic diseases. Such intake can either occur directly from electronic medical records using appropriate software to capture these evidence-based parameters or from a secure, web-accessible system available on the Know Your Number Web site. This information, which is anonymous, can then be sent directly to various performance assessment organizations supporting BTE. This serves to streamline and facilitate participation.

BioSignia’s predictive engine significantly improves prevention and management of chronic diseases by focusing on individualized specific disease risks. An ancillary value, which drives care quality at the physician level, is the Know Your Number decision-support tool for physicians. This addresses individual morbidity load, health risks and care guidelines. The program also has important elements to drive both physician/patient communication and aggregation of information to study outcomes. This series of quality-enhancement reports is made possible using Synthesis Analysis™, BioSignia's patented synthesis modeling technology.

“The idea behind our relationship with Bridges to Excellence was to provide a continuous channel between BioSignia and the medical community so that more physicians could benefit from this tool,” says Smith. “When we created Know Your Number, we knew it would reinvent physician care quality as we know it.”

About Bridges to Excellence
Bridges to Excellence is a not-for-profit organization developed by employers, physicians, health care services, researchers, and other industry experts with a mission to create significant leaps in the quality of care by recognizing and rewarding health care providers who demonstrate that they have implemented comprehensive solutions in the management of patients and deliver safe, timely, effective, efficient, equitable and patient-centered care. BTE is a not-for-profit organization that designs and creates programs that encourage physicians and physician practices to deliver safer, more effective and efficient care through financial and other incentives. For more information visit: http://www.bridgestoexcellence.org/

About BioSignia

Headquartered in Research Triangle Park, N.C., BioSignia is a leading technology company focused on bringing innovative predictive modeling solutions to the preventive health and life insurance markets. At the core of BioSignia’s flagship solution, Know Your Number is the company’s proprietary synthesis modeling approach to chronic disease risk prediction. In 2004, BioSignia received the Disease Management Association of America’s prestigious award for Best Enabling Tool for Disease Management. Since then, the company’s talented R&D team has continued to advance synthesis modeling, continuously updating it to reflect the ever expanding need for effective chronic disease prevention, management and treatment. For more information, visit: http://www.knowyournumber.com

Contact:
Alison Kramer
919-459-8157
akramer@919marketing.com

Press Release Source: http://PressExposure.com/PR/BioSignia.html